Clearbridge Health Limited (SGX:1H3)

Clearbridge Health Statistics

Total Valuation

SGXC:1H3 has a market cap or net worth of SGD 8.59 million. The enterprise value is 10.47 million.

Market Cap	8.59M
Enterprise Value	10.47M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

SGXC:1H3 has 4.30 billion shares outstanding. The number of shares has increased by 93.03% in one year.

Current Share Class	4.30B
Shares Outstanding	4.30B
Shares Change (YoY)	+93.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	19.86%
Owned by Institutions (%)	2.07%
Float	2.82B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.84
PB Ratio	0.62
P/TBV Ratio	6.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.97
EV / Sales	1.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.76

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.10.

Current Ratio	1.73
Quick Ratio	1.01
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-1.22
Interest Coverage	-7.66

Financial Efficiency

Return on equity (ROE) is -25.58% and return on invested capital (ROIC) is -12.86%.

Return on Equity (ROE)	-25.58%
Return on Assets (ROA)	-11.01%
Return on Invested Capital (ROIC)	-12.86%
Return on Capital Employed (ROCE)	-21.94%
Revenue Per Employee	80,242
Profits Per Employee	-20,586
Employee Count	128
Asset Turnover	0.55
Inventory Turnover	22.55

Taxes

Income Tax	-18,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.00% in the last 52 weeks. The beta is 0.43, so SGXC:1H3's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-75.00%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	43.61
Average Volume (20 Days)	2,459,670

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:1H3 had revenue of SGD 10.27 million and -2.64 million in losses. Loss per share was -0.00.

Revenue	10.27M
Gross Profit	5.11M
Operating Income	-3.32M
Pretax Income	-3.09M
Net Income	-2.64M
EBITDA	-3.10M
EBIT	-3.32M
Loss Per Share	-0.00

Balance Sheet

The company has 1.29 million in cash and 1.45 million in debt, giving a net cash position of -168,000 or -0.00 per share.

Cash & Cash Equivalents	1.29M
Total Debt	1.45M
Net Cash	-168,000
Net Cash Per Share	-0.00
Equity (Book Value)	13.92M
Book Value Per Share	0.00
Working Capital	2.17M

Cash Flow

In the last 12 months, operating cash flow was -1.10 million and capital expenditures -98,000, giving a free cash flow of -1.20 million.

Operating Cash Flow	-1.10M
Capital Expenditures	-98,000
Free Cash Flow	-1.20M
FCF Per Share	-0.00

Margins

Gross margin is 49.71%, with operating and profit margins of -32.29% and -25.65%.

Gross Margin	49.71%
Operating Margin	-32.29%
Pretax Margin	-30.11%
Profit Margin	-25.65%
EBITDA Margin	-30.20%
EBIT Margin	-32.29%
FCF Margin	n/a

Dividends & Yields

SGXC:1H3 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-93.03%
Shareholder Yield	-93.03%
Earnings Yield	-30.67%
FCF Yield	-13.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:1H3 has an Altman Z-Score of -5.99 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.99
Piotroski F-Score	4